Overexpression of PTK2 has been described in a diverse assortment of human tumors, including breast cancer (Sethuraman et al., 2016), hepatocellular carcinoma, and head and neck cell carcinoma (Fan et al., 2019). Here, PTK2 is linked to breast cancer.